# ImmunityBio, Inc.: Form 8-K, filed Jan 15, 2026

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2026-01-15
- Accepted by EDGAR: Jan 15, 2026, 13:35 ET
- Period: 2026-01-15
- Accession: 0001326110-26-000008
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/ibrx-20260115.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/ibrx-20260115.htm

Filed Jan 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001326110-26-000008. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.